company logo

Software Engineer (Genomics) in South San Francisco, CA

Myriad Genetics, Inc

South San Francisco, CA 94080
6w ago
Save

specialty:

Software Development

experience:

Less than 5 years

Job Description

Our tests are powered by an automated sequencing lab and software that truly covers the full technology stack: robotics, automation, scientific compute, data pipelines, variant calling/interpretation (bioinformatics), data visualization, risk calculations (population genetics), electronic medical records (EMR), patient and doctor user experience (UX), and solving key workflow problems in large complex health systems. This technology stack enables us to provide actionable information to almost a million patients per year.

Responsibilities

About the position

Each patient sample can contain thousands of mutations. The genomics team is charged with the clinical interpretation of these mutations – going from those thousands to the few that cause rare diseases, predispose you to elevated cancer risks or challenge the health of your pregnancy.

The software you write, above all else, ensures accurate results for patients but

See More

Valid through: 2020-3-4

About Myriad Genetics

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individuals risk for developing disease later in life (predictive medicine), identify a patients likelihood of responding to a particular drug therapy (personalized medicine), assess a patients risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriads discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: “There is no more exciting story in medical science.” Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics. In August 2016 Myriad announced it would acquire Assurex Health for up to $410 million, expanding the companys genetic testing for psychotropic medicine selection. The global search for the genetic basis of breast and ovarian cancers began in earnest in 1988. In 1990, at an American Society of Human Genetics Meeting, a team of scientists led by Mary-Claire King, Ph.D., from University of California, Berkeley announced the localization through linkage analysis of a gene associated with increased risk for breast cancer (BRCA1) to the long arm of chromosome 17. In August 1994, Mark Skolnick and researchers at Myriad, along with colleagues at the University of Utah, the U.S National Institutes of Health (NIH), and McGill University sequenced BRCA1. In 2013, the actress Angelina Jolie had her ovaries removed because she tested positive for a mutation in the BRCA1 gene. This led to a surge in demand by women for genetic testing.
Total Jobs:
53
Total Experts:
5
Average Pay:
$114,312
Total value of jobs:
$9,145,000
% Masters:
36%

Myriad Genetics Photos

company social media photocompany social media photocompany social media photocompany social media photo
* Ladders Estimates